Annual Net Income
-$74.81 M
+$108.29 M+59.14%
31 December 2021
Summary:
Aerie Pharmaceuticals annual net profit is currently -$74.81 million, with the most recent change of +$108.29 million (+59.14%) on 31 December 2021. During the last 3 years, it has risen by +$108.29 million (+59.14%).AERI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$26.83 M
-$7.46 M-38.49%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly net profit is currently -$26.83 million, with the most recent change of -$7.46 million (-38.49%) on 30 September 2022.AERI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$36.55 M
+$12.87 M+26.03%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM net profit is currently -$36.55 million, with the most recent change of +$12.87 million (+26.03%) on 30 September 2022.AERI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +59.1% | +32.4% | +78.0% |
| 5 y5 years | +67.8% | +45.7% | +81.3% |
AERI Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +476.9% | -158.9% | +917.7% |
Aerie Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$26.83 M(+38.5%) | -$36.55 M(-26.0%) |
| June 2022 | - | -$19.37 M(-46.0%) | -$49.42 M(-28.1%) |
| Mar 2022 | - | -$35.89 M(-178.8%) | -$68.74 M(-8.1%) |
| Dec 2021 | -$74.81 M(-59.1%) | $45.53 M(-214.7%) | -$74.81 M(-55.1%) |
| Sept 2021 | - | -$39.69 M(+2.6%) | -$166.48 M(+0.0%) |
| June 2021 | - | -$38.69 M(-7.8%) | -$166.44 M(-5.4%) |
| Mar 2021 | - | -$41.96 M(-9.0%) | -$175.94 M(-3.9%) |
| Dec 2020 | -$183.10 M(-8.3%) | -$46.14 M(+16.4%) | -$183.10 M(-4.6%) |
| Sept 2020 | - | -$39.65 M(-17.7%) | -$192.03 M(-4.8%) |
| June 2020 | - | -$48.19 M(-1.9%) | -$201.78 M(+0.5%) |
| Mar 2020 | - | -$49.13 M(-10.8%) | -$200.76 M(+0.6%) |
| Dec 2019 | -$199.58 M(-14.2%) | -$55.06 M(+11.5%) | -$199.58 M(+1.8%) |
| Sept 2019 | - | -$49.40 M(+4.7%) | -$195.97 M(-15.5%) |
| June 2019 | - | -$47.16 M(-1.6%) | -$231.96 M(-3.3%) |
| Mar 2019 | - | -$47.95 M(-6.8%) | -$239.82 M(+3.1%) |
| Dec 2018 | -$232.57 M(+60.3%) | -$51.46 M(-39.7%) | -$232.57 M(-2.9%) |
| Sept 2018 | - | -$85.39 M(+55.2%) | -$239.62 M(+28.4%) |
| June 2018 | - | -$55.02 M(+35.2%) | -$186.61 M(+16.6%) |
| Mar 2018 | - | -$40.70 M(-30.4%) | -$160.02 M(+10.3%) |
| Dec 2017 | -$145.10 M | -$58.51 M(+80.8%) | -$145.10 M(+25.2%) |
| Sept 2017 | - | -$32.37 M(+13.9%) | -$115.91 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$28.43 M(+10.3%) | -$107.36 M(+5.1%) |
| Mar 2017 | - | -$25.79 M(-12.1%) | -$102.14 M(+3.1%) |
| Dec 2016 | -$99.06 M(+33.2%) | -$29.32 M(+23.1%) | -$99.06 M(+9.9%) |
| Sept 2016 | - | -$23.81 M(+2.6%) | -$90.11 M(+6.9%) |
| June 2016 | - | -$23.22 M(+2.3%) | -$84.26 M(+5.6%) |
| Mar 2016 | - | -$22.70 M(+11.4%) | -$79.83 M(+7.3%) |
| Dec 2015 | -$74.36 M(+54.5%) | -$20.38 M(+13.5%) | -$74.36 M(+5.5%) |
| Sept 2015 | - | -$17.96 M(-4.4%) | -$70.49 M(+7.3%) |
| June 2015 | - | -$18.79 M(+9.0%) | -$65.67 M(+11.9%) |
| Mar 2015 | - | -$17.24 M(+4.5%) | -$58.70 M(+22.0%) |
| Dec 2014 | -$48.13 M(+54.5%) | -$16.50 M(+25.5%) | -$48.13 M(+14.8%) |
| Sept 2014 | - | -$13.15 M(+11.3%) | -$41.91 M(+6.1%) |
| June 2014 | - | -$11.81 M(+77.1%) | -$39.52 M(+16.1%) |
| Mar 2014 | - | -$6.67 M(-35.1%) | -$34.03 M(+9.2%) |
| Dec 2013 | -$31.15 M(+108.0%) | -$10.28 M(-4.3%) | -$31.15 M(+27.6%) |
| Sept 2013 | - | -$10.75 M(+69.8%) | -$24.41 M(+41.5%) |
| June 2013 | - | -$6.33 M(+67.0%) | -$17.25 M(+57.9%) |
| Mar 2013 | - | -$3.79 M(+6.9%) | -$10.93 M(+53.1%) |
| Dec 2012 | -$14.98 M(+15.5%) | -$3.54 M(-1.3%) | -$7.14 M(+98.7%) |
| Sept 2012 | - | -$3.59 M | -$3.59 M |
| Dec 2011 | -$12.97 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual net profit?
- What is the all time high annual net income for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual net profit?
The current annual net income of AERI is -$74.81 M
What is the all time high annual net income for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual net profit is -$12.97 M
What is Aerie Pharmaceuticals quarterly net profit?
The current quarterly net income of AERI is -$26.83 M
What is the all time high quarterly net income for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly net profit is $45.53 M
What is Aerie Pharmaceuticals TTM net profit?
The current TTM net income of AERI is -$36.55 M
What is the all time high TTM net income for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM net profit is -$3.59 M